Zions Bancorporation, N.A. Bristol Myers Squibb CO Transaction History

Zions Bancorporation, N.A.

$1.58 Billion
Q4 2024

A detailed history of Zions Bancorporation, N.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 188,331 shares of BMY stock, worth $8.84 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

188,331

Previous 167,851 12.2%

Holding current value

$8.84 Million

Previous $8.69 Million 22.63%

% of portfolio

0.68%

Previous 0.64%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$51.92 - $59.94 $1.06 Million - $1.23 Million	20,480 Added 12.2%	188,331 $10.7 Million
Q3 2024 Nov 06, 2024	BUY	$39.66 - $51.75 $912,219 - $1.19 Million	23,001 Added 15.88%	167,851 $8.69 Million
Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $2.12 Million - $2.79 Million	52,587 Added 57.0%	144,850 $6.02 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $4.23 Million - $4.79 Million	88,126 Added 2130.19%	92,263 $5 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $1,405 - $1,677	-29 Reduced 0.7%	4,137 $212,000
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $7,583 - $8,479	-131 Reduced 3.05%	4,166 $241,000
Q2 2023 Jul 28, 2023	SELL	$63.71 - $70.74 $10,321 - $11,459	-162 Reduced 3.63%	4,297 $274,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $788 - $894	12 Added 0.27%	4,459 $309,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $1.61 Million - $1.9 Million	-23,487 Reduced 84.08%	4,447 $319,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $2,927 - $1.73 Million	-22,521 Reduced 44.64%	27,934 $1.99 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $917,481 - $1.01 Million	-12,634 Reduced 20.03%	50,455 $3.89 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $2.3 Million - $2.76 Million	37,473 Added 146.29%	63,089 $4.61 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $1.27 Million - $1.48 Million	23,722 Added 1252.48%	25,616 $1.6 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $3,786 - $4,435	-64 Reduced 3.27%	1,894 $112,000
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $31,202 - $33,979	-504 Reduced 20.47%	1,958 $131,000
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $872,535 - $981,344	-14,704 Reduced 85.66%	2,462 $155,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $42,785 - $48,483	-741 Reduced 4.14%	17,166 $1.07 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $266,877 - $295,735	4,647 Added 35.05%	17,907 $1.08 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $588,383 - $687,877	10,733 Added 424.73%	13,260 $780,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $77,441 - $112,540	-1,669 Reduced 39.78%	2,527 $141,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $25,490 - $33,250	518 Added 14.08%	4,196 $269,000
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $47,603 - $56,440	-1,113 Reduced 23.23%	3,678 $186,000
Q2 2019 Jul 09, 2019	BUY	$44.62 - $49.34 $6,514 - $7,203	146 Added 3.14%	4,791 $218,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $209,582 - $249,901	4,645 New	4,645 $222,000

Others Institutions Holding BMY

# of Institutions

2,810

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.8B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account

Zions Bancorporation, N.A. Bristol Myers Squibb CO Transaction History